Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1

Phase 3

Completed

• Conditions: Substance-Related Disorders

• Registration Number: NCT00033020
• Lead Sponsor: Johns Hopkins University

Brief Summary

The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

Detailed Description

The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics. The study will determine if motivational incentives along with standard care therapy is more effective than standard therapy alone for the treatment of patients using cocaine or methamphetamine and entering a substance abuse treatment program.

Study Timeline

• Study Start: 2001-04
• Study First Submitted: 2002-04-05
• Study First Submitted QC: 2002-04-05
• Study First Posted: 2002-04-08
• Primary Completion: 2003-02
• Study Completion: 2003-02
• Status Verified: 2010-04
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 390

Inclusion Criteria

1. Recent admission to an opioid substitution (methadone maintenance) CTP. Completed at least 4 weeks of maintenance at time of study entry
2. Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment

Read More

Exclusion Criteria

1. Unable to give informed consent (fails simple consent quiz)
2. Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ASI
AIDS risk behavior
Opioid and cocaine use

Trial Locations

Locations (7)

Aegis Medical Systems, Inc.; 🇺🇸 Bakersfield, California, United States

Oasis Clinic; 🇺🇸 Washington, District of Columbia, United States

Glenwood Life Counseling Center; 🇺🇸 Baltimore, Maryland, United States

Lower Eastside Service Center (LESC); 🇺🇸 New York, New York, United States

Greenwich House, Inc.; 🇺🇸 New York, New York, United States

Charleston Center; 🇺🇸 Charleston, South Carolina, United States

ACT; 🇺🇸 Philadelphia, Pennsylvania, United States